These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15947885)

  • 1. Aldosterone and heart failure: the rest of the story.
    Williams GH
    Heart Fail Rev; 2005 Jan; 10(1):5-6. PubMed ID: 15947885
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone in heart failure: pathophysiology and treatment.
    Struthers AD
    Curr Heart Fail Rep; 2004 Dec; 1(4):171-5. PubMed ID: 16036041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone in congestive heart failure.
    Weber KT
    N Engl J Med; 2001 Dec; 345(23):1689-97. PubMed ID: 11759649
    [No Abstract]   [Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The EMPHASIS-HF study].
    Boccanelli A; Agostoni P
    G Ital Cardiol (Rome); 2011 May; 12(5):315-8. PubMed ID: 21593949
    [No Abstract]   [Full Text] [Related]  

  • 6. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
    Sexton DJ
    Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129
    [No Abstract]   [Full Text] [Related]  

  • 7. A mechanism for mineralocortcoid participation in renal disease and heart failure.
    Re RN
    J Am Soc Hypertens; 2015 Aug; 9(8):586-91. PubMed ID: 26101172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.
    Zannad F; Radauceanu A
    Heart Fail Rev; 2005 Jan; 10(1):71-8. PubMed ID: 15947894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of aldosterone blockers in the management of chronic heart failure.
    Coca SG; Perazella MA
    Am J Med Sci; 2005 Oct; 330(4):176-83. PubMed ID: 16234610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and renin-angiotensin-aldosterone system: studies on aldosterone].
    Yoshimura M
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):195-200. PubMed ID: 15768580
    [No Abstract]   [Full Text] [Related]  

  • 11. A primer on aldosterone for gynecologists/obstetricians.
    Pitt B
    J Reprod Med; 2007 Feb; 52(2 Suppl):153-8. PubMed ID: 17477109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F; Lang CC; Struthers AD
    Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New twist to the role of the renin-angiotensin system in heart failure: aldosterone upregulates renin-angiotensin system components in the brain.
    Schiffrin EL
    Hypertension; 2008 Mar; 51(3):622-3. PubMed ID: 18212262
    [No Abstract]   [Full Text] [Related]  

  • 14. Aldosterone and artery compliance in heart failure.
    Struthers A
    Eur Heart J; 1998 Sep; 19(9):1273. PubMed ID: 9792248
    [No Abstract]   [Full Text] [Related]  

  • 15. Eplerenone: cardiovascular protection.
    Brown NJ
    Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are mineralocorticoid receptor antagonists cardioprotective?
    Chai W; Danser AH
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):153-62. PubMed ID: 17075718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone blockade in CKD: emphasis on pharmacology.
    Schwenk MH; Hirsch JS; Bomback AS
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):123-32. PubMed ID: 25704349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone antagonists in heart failure.
    Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
    van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH
    Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy.
    Tan LB; Schlosshan D; Barker D
    Int J Cardiol; 2004 Sep; 96(3):321-33. PubMed ID: 15310530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.